← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Kannalife Sciences, Inc.
Lloyd Harbor, NY
$3,270,688
Total funding
2
Grants
Funding over time
peak $1M · FY2018–23$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,270,688 · 2
By mechanism
R42$2,970,772 · 1
R41$299,916 · 1
Investigators at Kannalife Sciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of KLS-13019 for Neuropathic Pain$1,001,774
R42 · FY2023 · NS
Development of KLS-13019 for Neuropathic Pain$991,944
R42 · FY2022 · NS
Development of KLS-13019 for Neuropathic Pain$977,054
R42 · FY2021 · NS
Development of KLS-13019 for Chemotherapy Induced Peripheral Neuropathy and Drug Dependence$299,916
R41 · FY2018 · DA